Cargando…
Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364820/ https://www.ncbi.nlm.nih.gov/pubmed/37492861 http://dx.doi.org/10.2147/PRBM.S406347 |
_version_ | 1785076923093745664 |
---|---|
author | Nagaoka, Maki Koreki, Akihiro Kosugi, Teppei Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro |
author_facet | Nagaoka, Maki Koreki, Akihiro Kosugi, Teppei Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro |
author_sort | Nagaoka, Maki |
collection | PubMed |
description | PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from the employer’s perspective in parallel with a randomized controlled trial. Of the 90 healthy participants, 50 met the inclusion criteria and were randomized to the MBCT group (n = 25) or wait-list control group (n = 25). In the CUA, intervention costs and healthcare costs were included, while the mean difference in the change in quality-adjusted life years (QALYs) between the baseline and 16-week follow-up was used as an indicator of effect. Incremental cost-effectiveness ratio (ICER) was produced, and uncertainty was addressed using non-parametric bootstrapping with 5000 replications. In the CBA, the change in productivity losses was reflected as a benefit, while the costs included intervention and healthcare costs. The net monetary benefit was calculated, and uncertainty was handled with 5000 bootstrapping. Healthcare costs were measured with the self-report Health Service Use Inventory. The purchasing power parity in 2019 was used for currency conversion. RESULTS: In the CUA, incremental costs and QALYs were estimated at JPY 19,700 (USD 189) and 0.011, respectively. The ICER then became JPY 1,799,435 (USD 17,252). The probability of MBCT being cost-effective was 92.2% at the threshold of 30,000 UK pounds per QALY. The CBA revealed that MBCT resulted in increased costs (JPY 24,180) and improved work productivity (JPY 130,640), with a net monetary benefit of JPY 106,460 (USD 1021). The probability of the net monetary benefit being positive was 69.6%. CONCLUSION: The results suggested that MBCT may be more cost-effective from a healthcare sector perspective and may be cost-beneficial from the employer’s perspective. |
format | Online Article Text |
id | pubmed-10364820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103648202023-07-25 Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults Nagaoka, Maki Koreki, Akihiro Kosugi, Teppei Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro Psychol Res Behav Manag Original Research PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from the employer’s perspective in parallel with a randomized controlled trial. Of the 90 healthy participants, 50 met the inclusion criteria and were randomized to the MBCT group (n = 25) or wait-list control group (n = 25). In the CUA, intervention costs and healthcare costs were included, while the mean difference in the change in quality-adjusted life years (QALYs) between the baseline and 16-week follow-up was used as an indicator of effect. Incremental cost-effectiveness ratio (ICER) was produced, and uncertainty was addressed using non-parametric bootstrapping with 5000 replications. In the CBA, the change in productivity losses was reflected as a benefit, while the costs included intervention and healthcare costs. The net monetary benefit was calculated, and uncertainty was handled with 5000 bootstrapping. Healthcare costs were measured with the self-report Health Service Use Inventory. The purchasing power parity in 2019 was used for currency conversion. RESULTS: In the CUA, incremental costs and QALYs were estimated at JPY 19,700 (USD 189) and 0.011, respectively. The ICER then became JPY 1,799,435 (USD 17,252). The probability of MBCT being cost-effective was 92.2% at the threshold of 30,000 UK pounds per QALY. The CBA revealed that MBCT resulted in increased costs (JPY 24,180) and improved work productivity (JPY 130,640), with a net monetary benefit of JPY 106,460 (USD 1021). The probability of the net monetary benefit being positive was 69.6%. CONCLUSION: The results suggested that MBCT may be more cost-effective from a healthcare sector perspective and may be cost-beneficial from the employer’s perspective. Dove 2023-07-20 /pmc/articles/PMC10364820/ /pubmed/37492861 http://dx.doi.org/10.2147/PRBM.S406347 Text en © 2023 Nagaoka et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Nagaoka, Maki Koreki, Akihiro Kosugi, Teppei Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title | Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title_full | Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title_fullStr | Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title_full_unstemmed | Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title_short | Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults |
title_sort | economic evaluation alongside a randomized controlled trial of mindfulness-based cognitive therapy in healthy adults |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364820/ https://www.ncbi.nlm.nih.gov/pubmed/37492861 http://dx.doi.org/10.2147/PRBM.S406347 |
work_keys_str_mv | AT nagaokamaki economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults AT korekiakihiro economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults AT kosugiteppei economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults AT ninomiyaakira economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults AT mimuramasaru economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults AT sadomitsuhiro economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults |